BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 33959860)

  • 1. Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients.
    Muthiah MD; Zheng H; Chew NWS; Xiao J; Lim LG; Tan HC; Lee CH; Low AF; Foo LL; Richards AM; Dan YY; Ho KY; Yip JWL; Chan MY
    J Thromb Thrombolysis; 2021 Oct; 52(3):925-933. PubMed ID: 33959860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
    Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.
    Simon T; Steg PG; Gilard M; Blanchard D; Bonello L; Hanssen M; Lardoux H; Coste P; Lefèvre T; Drouet E; Mulak G; Bataille V; Ferrières J; Verstuyft C; Danchin N
    Circulation; 2011 Feb; 123(5):474-82. PubMed ID: 21262992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
    Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
    Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
    Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
    J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.
    Dunn SP; Steinhubl SR; Bauer D; Charnigo RJ; Berger PB; Topol EJ
    J Am Heart Assoc; 2013 Jan; 2(1):e004564. PubMed ID: 23525436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
    Zhong Z; Hou J; Zhang Q; Li B; Li C; Liu Z; Yang M; Zhong W; He X; Wu H; Zhong M; Zhao P
    Eur J Clin Pharmacol; 2018 Apr; 74(4):423-431. PubMed ID: 29243114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel with or without omeprazole in coronary artery disease.
    Bhatt DL; Cryer BL; Contant CF; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Scirica BM; Murphy SA; Cannon CP;
    N Engl J Med; 2010 Nov; 363(20):1909-17. PubMed ID: 20925534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
    Drepper MD; Spahr L; Frossard JL
    World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CYP2C19 G681A polymorphism and omeprazole on clopidogrel responsiveness and impact in patients with acute coronary syndrome.
    Jirungda S; Pussadhamma B; Komanasin N; Senthong V; Leuangwatthananon W
    Coron Artery Dis; 2020 May; 31(3):266-272. PubMed ID: 31658140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between clopidogrel and proton pump inhibitors].
    Harmsze AM; de Boer A; Boot H; Deneer VH; Heringa M; Mol PG; Schalekamp T; Verduijn MM; Verheugt FW; le Comte M
    Ned Tijdschr Geneeskd; 2011; 155(28):A2442. PubMed ID: 21771377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.
    Yamane K; Kato Y; Tazaki J; Tada T; Makiyama T; Imai M; Jinnai T; Ikeda T; Shirakawa R; Kimura T; Horiuchi H
    J Atheroscler Thromb; 2012; 19(6):559-69. PubMed ID: 22472213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
    Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
    JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.